New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

by University of Massachusetts AmherstBacterial delivery of ovalbumin induces a specific CD8 T cell response. Credit:Frontiers in Immunology(2023). DOI: 10.3389/fimmu.2023.1228532A Un
Oncology May 05,2024
Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

Proof-of-principle study shows immunity from routine vaccines has potential to fight cancer

by University of Massachusetts AmherstBacterial delivery of ovalbumin induces a specific CD8 T cell response. Credit:Frontiers in Immunology(2023). DOI: 10.3389/fimmu.2023.1228532A Un
Oncology May 05,2024
Herd protection against oral HPV infections seen among men

Herd protection against oral HPV infections seen among men

In unvaccinated men aged 18 to 59 years, the prevalence of vaccine-type oral human papillomavirus (HPV) decreased between 2009 to 2010 and 2015 to 2016, according to a research letter published in the
Oncology May 05,2024
Herd protection against oral HPV infections seen among men

Herd protection against oral HPV infections seen among men

In unvaccinated men aged 18 to 59 years, the prevalence of vaccine-type oral human papillomavirus (HPV) decreased between 2009 to 2010 and 2015 to 2016, according to a research letter published in the
Oncology May 05,2024
Exercise associated with benefit to patients with advanced colorectal cancer

Exercise associated with benefit to patients with advanced colorectal cancer

by Dana-Farber Cancer InstituteDr. Meyerhardt is the clinical director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and the senior author of the study. Credit: Dana-Farbe
Oncology May 05,2024
Exercise associated with benefit to patients with advanced colorectal cancer

Exercise associated with benefit to patients with advanced colorectal cancer

by Dana-Farber Cancer InstituteDr. Meyerhardt is the clinical director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and the senior author of the study. Credit: Dana-Farbe
Oncology May 05,2024
Telerehabilitation aids function, pain with advanced cancer

Telerehabilitation aids function, pain with advanced cancer

(HealthDay)—Collaborative telerehabilitation modestly improves function and pain while decreasing hospital length of stay and the need for postacute care in advanced cancer patients, according to a st
Oncology May 05,2024
Telerehabilitation aids function, pain with advanced cancer

Telerehabilitation aids function, pain with advanced cancer

(HealthDay)—Collaborative telerehabilitation modestly improves function and pain while decreasing hospital length of stay and the need for postacute care in advanced cancer patients, according to a st
Oncology May 05,2024
Chronic diseases monitored in primary care could lead to unnecessary testing

Chronic diseases monitored in primary care could lead to unnecessary testing

by University of BristolCredit: CC0 Public DomainGuidelines used by GPs to monitor chronic diseases are based on expert opinion rather than evidence, according to a review of the guidelines by Na
Oncology May 05,2024
Chronic diseases monitored in primary care could lead to unnecessary testing

Chronic diseases monitored in primary care could lead to unnecessary testing

by University of BristolCredit: CC0 Public DomainGuidelines used by GPs to monitor chronic diseases are based on expert opinion rather than evidence, according to a review of the guidelines by Na
Oncology May 05,2024
Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

by University of California - San DiegoIn a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the ta
Oncology May 05,2024
Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

by University of California - San DiegoIn a patient-derived tumor model in mice, glioblastoma tumors (dark purple) shrink significantly when treated with both the MS drug teriflunomide and the ta
Oncology May 05,2024
Performance on exercise test predicts risk of death from cardiovascular disease and cancer

Performance on exercise test predicts risk of death from cardiovascular disease and cancer

by European Society of CardiologyCredit: CC0 Public DomainPerformance on an exercise test predicts the risk of death from cardiovascular disease, cancer, and other causes, reports a study present
Oncology May 05,2024
Performance on exercise test predicts risk of death from cardiovascular disease and cancer

Performance on exercise test predicts risk of death from cardiovascular disease and cancer

by European Society of CardiologyCredit: CC0 Public DomainPerformance on an exercise test predicts the risk of death from cardiovascular disease, cancer, and other causes, reports a study present
Oncology May 05,2024
Healthy habits could prevent 27% of cancer cases in Brazil

Healthy habits could prevent 27% of cancer cases in Brazil

by Maria Fernanda Ziegler,FAPESPA study by Brazilian researchers in partnership with Harvard estimates the impact of five risk factors on the incidence of cancer- physical inactivity, unhealthy
Oncology May 05,2024
Healthy habits could prevent 27% of cancer cases in Brazil

Healthy habits could prevent 27% of cancer cases in Brazil

by Maria Fernanda Ziegler,FAPESPA study by Brazilian researchers in partnership with Harvard estimates the impact of five risk factors on the incidence of cancer- physical inactivity, unhealthy
Oncology May 05,2024
COVID-19 antibody discovery could explain long COVID

COVID-19 antibody discovery could explain long COVID

byUniversity of VirginiaSchematic diagram illustrating the hypothesis underlying the study. The SARS-CoV-2 spike protein RBD binds ACE2 on the surface of potential host cells. The RBD has a part
Public Health & Prevention April 30,2024
COVID-19 antibody discovery could explain long COVID

COVID-19 antibody discovery could explain long COVID

byUniversity of VirginiaSchematic diagram illustrating the hypothesis underlying the study. The SARS-CoV-2 spike protein RBD binds ACE2 on the surface of potential host cells. The RBD has a part
Public Health & Prevention April 30,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com